Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TET2 | Q6N021 | 3/20 | 0.33 |
| ▸ | TET3 | O43151 | 1/20 | 0.33 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.33 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.32 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.32 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.32 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4447284 | 0.75 | TET2 (0.31) | TET2TET3TET1GRIK1GRIK2 | |
| SCHEMBL3234240 | 0.74 | TRPA1 (0.31) | — | |
| SCHEMBL9857356 | 0.74 | TET2 (0.33) | TET2TET3TET1 | |
| SCHEMBL3880567 | 0.74 | TSHR (0.41) | TET2TET3TET1GRIK1GRIK2 | |
| SCHEMBL2808088 | 0.74 | TET2 (0.35) | TET2TET3TET1GRIK1GRIK2 | |
| SCHEMBL10709816 | 0.72 | — | — | |
| SCHEMBL23494224 | 0.72 | RNPEP (0.35) | TET2TET3TET1GRIK1GRIK2 | |
| SCHEMBL439461 | 0.72 | TSHR (0.39) | TET2TET3TET1GRIK1GRIK2 | |
| SCHEMBL7361579 | 0.71 | BHMT (0.35) | — | |
| SCHEMBL346413 | 0.71 | TET2 (0.37) | TET2TET3TET1GRIK1GRIK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100210812-A1 | CURABLE COMPOSITION AND CURED PRODUCT THEREOF | SHOWA DENKO K.K. (JP) | 2010-08-19 | — | — | US | disclosed |
| US-20100087611-A1 | URETHANE COMPOUND, CURABLE COMPOSITION CONTAINING THE SAME, AND CURED PRODUCT THEREOF | SHOWA DENKO K.K. (JP) | 2010-04-08 | — | — | US | disclosed |
| US-4774178-A | Immobilization of biological material within a polymer matrix | BAYER AKTIENGESELLSCHAFT (DE) | 1988-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087611-A1 | URETHANE COMPOUND, CURABLE COMPOSITION CONTAINING THE SAME, AND CURED PRODUCT THEREOF | ITCH, GLI1, UNC119 | TET2 539/4885TET3 242/4885TET1 199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.